Brain and cord myelin water imaging: A progressive multiple sclerosis biomarker
2015
Objectives
Conventional magnetic resonance imaging (MRI) is used to diagnose and monitor inflammatory disease in relapsing remitting (RR) multiple sclerosis (MS). In the less common primary progressive (PP) form of MS, in which focal inflammation is less evident, biomarkers are still needed to enable evaluation of novel therapies in clinical trials. Our objective was to characterize the association — across the brain and cervical spinal cord — between clinical disability measures in PPMS and two potential biomarkers (one for myelin, and one for atrophy, both resulting from the same imaging technique).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
54
References
35
Citations
NaN
KQI